# FDA Inspection 1081765 - SHL Pharma LLC - January 29, 2019

Source: https://www.keypedia.com/records/fda_inspections/shl-pharma-llc/171c6c4d-101e-4548-92e6-c2beeda28bcf
Source feed: FDA_Inspections

> FDA Inspection 1081765 for SHL Pharma LLC on January 29, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1081765
- Company Name: SHL Pharma LLC
- Inspection Date: 2019-01-29
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1280537 - 2025-08-28](https://www.keypedia.com/records/fda_inspections/shl-pharma-llc/61d903bf-8116-4895-b2e1-532c9f0d2aa6)
- [FDA Inspection 1280537 - 2025-08-28](https://www.keypedia.com/records/fda_inspections/shl-pharma-llc/870e65b8-446c-4fac-ad08-9874f7c60043)
- [FDA Inspection 953453 - 2015-12-14](https://www.keypedia.com/records/fda_inspections/shl-pharma-llc/c4352f43-f876-4d7f-842c-c793941993de)
- [FDA Inspection 953453 - 2015-12-14](https://www.keypedia.com/records/fda_inspections/shl-pharma-llc/859a7111-24b0-4345-8a5d-1edf313c5c3f)

Company: https://www.keypedia.com/companies/shl-pharma-llc/bf3ea56c-78f5-4e22-9b0f-ffe5ee693aa3

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c